Ioxilan
Generic Name: ioxilan
Manufactured by GUERBET. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IOXILAN (62%). Application: NDA020316.
Overview
Manufactured by GUERBET. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: IOXILAN (62%). Application: NDA020316.
Dosage
Available as injectable for injection use.
Related Medications
Empagliflozin, Metformin Hydrochloride
empagliflozin, metformin hydrochloride
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
11 DESCRIPTION SYNJARDY and SYNJARDY XR tablets for oral use contain: empagliflozin and metformin HCl. Empagliflozin Empagliflozin is an inhibitor of the SGLT2. The chemical name of empagliflozin is D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S). Its molecular formula is C 23 H 27 ClO 7 and the molecular weight is 450.91. The structural formula is: Empagliflozin is a white to yellowish, non-hygroscopic powder.
Epinephrine 0.15 Pediatrics
epinephrine 0.15 pediatrics
alpha-Adrenergic Agonist [EPC]
11 DESCRIPTION Epinephrine injection, USP auto-injectors, 0.3 mg and 0.15 mg, are single-dose auto-injectors and combination products containing drug and device components. Each epinephrine injection, USP auto-injector, 0.3 mg delivers a single dose of 0.3 mg epinephrine from epinephrine injection, USP 0.3 mg/0.3 mL in a sterile solution.
Darunavir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide
darunavir, cobicistat, emtricitabine, and tenofovir alafenamide
Cytochrome P450 3A Inhibitor [EPC]
11. DESCRIPTION SYMTUZA ® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) is a fixed-dose combination tablet. Darunavir is an inhibitor of the HIV-1 protease. Cobicistat is a mechanism-based inhibitor of cytochrome P450 (CYP) enzymes of the CYP3A family. Emtricitabine, a synthetic nucleoside analog of cytidine, is an HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI).
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.